{"id":"https://openalex.org/W3083035973","doi":"https://doi.org/10.1182/hem.v9.2.1182","title":"FDA Approval of the JAK Inhibitor Ruxolitinib and the Management of Patients with Myelofibrosis","display_name":"FDA Approval of the JAK Inhibitor Ruxolitinib and the Management of Patients with Myelofibrosis","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W3083035973","doi":"https://doi.org/10.1182/hem.v9.2.1182","mag":"3083035973"},"language":"en","primary_location":{"id":"doi:10.1182/hem.v9.2.1182","doi":"https://doi.org/10.1182/hem.v9.2.1182","is_oa":false,"landing_page_url":"https://doi.org/10.1182/hem.v9.2.1182","pdf_url":null,"source":{"id":"https://openalex.org/S4210170090","display_name":"The Hematologist","issn_l":"1551-8779","issn":["1551-8779"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320264","host_organization_name":"American Society of Hematology","host_organization_lineage":["https://openalex.org/P4310320264"],"host_organization_lineage_names":["American Society of Hematology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Hematologist","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065621786","display_name":"Jason R. Gotlib","orcid":"https://orcid.org/0000-0001-8253-6156","observed_orcids":["https://orcid.org/0000-0001-8253-6156"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jason Gotlib","raw_affiliation_strings":["Stanford University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University School of Medicine","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5065621786"],"corresponding_institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.4687626,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"9","issue":"2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":1.0},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.847000002861023},{"id":"https://openalex.org/keywords/myelofibrosis","display_name":"myelofibrosis","score":0.9869999885559082},{"id":"https://openalex.org/keywords/fda-approval","display_name":"FDA approval","score":0.8489999771118164},{"id":"https://openalex.org/keywords/drug-approval","display_name":"drug approval","score":0.5649999976158142},{"id":"https://openalex.org/keywords/clinical-management","display_name":"clinical management","score":0.8080000281333923}],"concepts":[{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.9872174263000488},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.9264569878578186},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6170259714126587},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.48881909251213074},{"id":"https://openalex.org/C2778886723","wikidata":"https://www.wikidata.org/wiki/Q3530324","display_name":"Tofacitinib","level":3,"score":0.46016666293144226},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4205438196659088},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33480116724967957},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3256905674934387},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.13072335720062256},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.08196339011192322},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/hem.v9.2.1182","doi":"https://doi.org/10.1182/hem.v9.2.1182","is_oa":false,"landing_page_url":"https://doi.org/10.1182/hem.v9.2.1182","pdf_url":null,"source":{"id":"https://openalex.org/S4210170090","display_name":"The Hematologist","issn_l":"1551-8779","issn":["1551-8779"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320264","host_organization_name":"American Society of Hematology","host_organization_lineage":["https://openalex.org/P4310320264"],"host_organization_lineage_names":["American Society of Hematology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Hematologist","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W2049965335","https://openalex.org/W2117026298","https://openalex.org/W2127559749","https://openalex.org/W2197956845","https://openalex.org/W2543681710","https://openalex.org/W2545659482","https://openalex.org/W2553187946","https://openalex.org/W2577276651","https://openalex.org/W4241718608"],"related_works":["https://openalex.org/W2020150996","https://openalex.org/W2792166634","https://openalex.org/W2903989375","https://openalex.org/W2044410928","https://openalex.org/W4391691383","https://openalex.org/W4244757272","https://openalex.org/W4256066294","https://openalex.org/W4303087110","https://openalex.org/W4389326836","https://openalex.org/W96046762"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-09-11T00:00:00"}